According to Immunovant's latest financial reports the company's current EPS (TTM) is -$3.07. In 2022 the company made an earnings per share (EPS) of -$2.64 a decrease over its 2021 EPS that were of -$2.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.90 | 9.74% |
2022 | -$2.64 | 27.69% |
2021 | -$2.07 | -2.26% |
2020 | -$2.11 | 668.98% |
2019 | -$0.27 |